Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Surg Pathol. 2017 Oct;41(10):1381–1389. doi: 10.1097/PAS.0000000000000900

Figure 3.

Figure 3

Two patients (15 and 16) with underlying NSCLC developed granulomatous dermatitis after receiving combination anti-PD-1 and anti-CTLA-4. Histologic patterns were of (A) sarcoidal-type granulomas and (B) a granuloma-annulare pattern (200× and 100× original magnification, respectively).